AI is revolutionizing the pharmaceutical industry, particularly in drug discovery, data interpretation, and efficiency improvement.
Challenges in AI integration include regulatory compliance, data availability and security, interpretability of AI models, and high implementation costs.
Crypto investors are showing interest in AI-based healthcare technologies due to the potential for security and efficiency offered by blockchain technology.
Venture capital investment in AI-enabled healthcare technologies is growing, indicating the increasing trust and importance of AI in the pharmaceutical sector.